Emerging market opportunities revolve around building and maintaining compliant pharmacovigilance departments adept at managing regulatory requirements. Focus on training for enhanced global safety ...

The life science industry faces opportunities in enhancing cGMP compliance by developing robust, risk-based Validation and Verification strategies. Training on creating effective Master Validation ...

In a continuing effort to improve the quality system effectiveness of human drug manufacturing sites, FDA revised MAPP 5014.1, Understanding CDER’s Risk-Based Site Selection Model (Site Selection MAPP ...

The International Council on Harmonization (ICH) has issued training materials to complement its revised Q9(R1) guideline on quality risk management aimed at assisting the pharmaceutical industry in ...

The World Health Organization (WHO) has published guidance to help national authorities design and implement risk-based food inspection systems. Risk-based inspection aims to use resources more ...